Fortune favors Forbes Medi-Tech for 2005
2005 is barely underway but Canadian Forbes Medi-Tech is already looking forward to a bumper year. The biopharmaceutical company yesterday announced revenue guidance of C$21 to C$22 million for the fiscal year ending 31 December 2005 - up at least 20...